查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606846

内分泌检测市场：按类型、技术、适应症和最终用户划分 - 2025-2030 年全球预测

Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Technology (Clinical Chemistry, Immunoassay, Tandem Mass Spectroscopy), Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年内分泌检测市场价值为27.9亿美元，预计2024年将达到30亿美元，复合年增长率为8.24%，到2030年将达到48.6亿美元。

内分泌测试分析体内荷尔蒙水平，这些荷尔蒙对于调节各种生理功能很重要。此测试对于诊断荷尔蒙失衡和相关疾病（例如甲状腺疾病、糖尿病和肾上腺功能障碍）至关重要。内分泌检测的应用涵盖医疗保健、製药和研究等许多领域，可以深入了解疾病机制和治疗效果。最终用途范围包括医院、诊断实验室和研究机构，这些测试是必不可少的。由于荷尔蒙失调的盛行率不断增加、诊断技术的进步以及对早期检测的日益重视，内分泌检测市场正在不断增长。主要促进成长因素包括检测设备的技术创新、人口老化以及与文明病增加。目前的机会存在于个人化医疗工作以及将人工智慧整合到诊断工具中，这可以提高准确性并缩短週转时间。然而，挑战依然存在，包括先进测试的高成本、监管障碍以及发展中地区的准入有限。此外，测试结果的变化和缺乏标准化测试进一步使市场扩张变得复杂。对于业务成长，有一些成熟的创新领域，包括开发非侵入性检测方法、就地检验解决方案以及改进数位健康平台以实现无缝资料共用和病人参与。研究还可以集中在了解细胞层面的荷尔蒙相互作用，这可能为治疗性介入开闢新的途径。市场动态具有竞争性和动态性，不断推动测试灵敏度和特异性的提升。进入这一领域的公司需要专注于策略伙伴关係、研发投资以及开拓需求未满足的市场，以抓住不断增长的需求，同时应对现有挑战。

主要市场统计
基准年[2023] 27.9亿美元
预计年份 [2024] 30亿美元
预测年份 [2030] 48.6亿美元
复合年增长率（%） 8.24%

市场动态：揭示快速发展的内分泌检测市场的关键市场洞察

供需的动态交互作用正在改变内分泌检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球内分泌疾病盛行率上升
    • 提高对早期发现内分泌疾病重要性的认识
    • 扩大就地检验设备的采用
  • 市场限制因素
    • 内分泌检测相关的高成本
  • 市场机会
    • 扩大分析和测试方法的技术进步
    • 完善医疗政策和报销制度
  • 市场挑战
    • 依赖传统的荷尔蒙检测法

波特五力：驾驭内分泌检测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解内分泌检测市场的外部影响

外部宏观环境因素对内分泌检测市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解内分泌检测市场的竞争状况

对内分泌检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵内分泌检测市场供应商绩效评估

FPNV定位矩阵是评估内分泌检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划内分泌检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对内分泌检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球内分泌疾病盛行率上升
      • 提高对早期发现内分泌疾病重要性的认识
      • 扩大就地检验设备的引进范围
    • 抑制因素
      • 内分泌检测相关的高成本
    • 机会
      • 扩大分析和测试方法的技术进步
      • 完善医疗政策和报销制度
    • 任务
      • 依赖传统的荷尔蒙测试
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章内分泌检测市场：依类型

  • 皮质醇测试
  • 硫酸去氢表雄酮（DHEAS）测试
  • 雌二醇（E2）测试
  • 滤泡刺激素(FSH) 测试
  • 人类绒毛膜促性腺激素分泌(hCG) 荷尔蒙测试
  • 胰岛素测试
  • 黄体激素（LH）测试
  • 黄体酮测试
  • 催乳素测试
  • 睪酮测试
  • 甲状腺刺激素（TSH）测试

第七章内分泌检测市场：依技术分类

  • 临床化学
  • 免疫检测
  • 串联式质谱法

第八章内分泌检测市场适应症

  • 爱迪生氏症
  • 库欣氏症
  • 糖尿病
  • 格雷夫兹病
  • 桥本氏甲状腺炎

第九章内分泌检测市场：依最终用户分类

  • 诊断中心
  • 医院
  • 调查机构

第十章 南北美洲内分泌检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区内分泌检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲内分泌检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • BioCheck Inc.
  • Biogenix Inc. Pvt. Ltd
  • bioMerieux SA
  • Blueprint Genetics Oy
  • Creative Diagnostics
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin SpA
  • Eagle Biosciences
  • EKF Diagnostics Holdings Plc
  • Eurofins Analytical Laboratories Inc.
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • MP Biomedicals, LLC
  • Ortho-Clinical Diagnostics, Inc.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
Product Code: MRR-69324464D0E6

The Endocrine Testing Market was valued at USD 2.79 billion in 2023, expected to reach USD 3.00 billion in 2024, and is projected to grow at a CAGR of 8.24%, to USD 4.86 billion by 2030.

Endocrine testing involves the analysis of hormone levels in the body, which are critical in regulating a variety of physiological functions. This testing is essential for diagnosing hormonal imbalances and related conditions such as thyroid disorders, diabetes, and adrenal dysfunction. The application of endocrine testing spans numerous fields, including healthcare, pharmaceuticals, and research, offering insights into disease mechanisms and treatment efficacy. End-use scope covers hospitals, diagnostic laboratories, and research institutions where such testing is integral. The market for endocrine testing is growing due to increasing prevalence of hormonal disorders, advancements in diagnostic technologies, and a rising emphasis on early detection. Key growth drivers include technological innovations in testing equipment, an aging population, and a rising incidence of lifestyle-related diseases. Current opportunities exist in the form of personalized medicine initiatives and the integration of artificial intelligence in diagnostic tools, which can enhance accuracy and reduce turnaround times. However, challenges persist, including high costs of advanced testing methods, regulatory hurdles, and limited access in developing regions. Moreover, variability in test results and the lack of standardized testing further complicate market expansion. For business growth, areas ripe for innovation include the development of non-invasive testing methods, point-of-care testing solutions, and improving digital health platforms for seamless data sharing and patient engagement. Research can also focus on understanding hormone interactions at a cellular level, which may open avenues for novel therapeutic interventions. The nature of the endocrine testing market is competitive and dynamic, with a continual push towards improved sensitivity and specificity of tests. Businesses venturing into this field should focus on strategic partnerships, investing in R&D, and exploring markets with unmet needs to capitalize on growing demand while addressing existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 2.79 billion
Estimated Year [2024] USD 3.00 billion
Forecast Year [2030] USD 4.86 billion
CAGR (%) 8.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endocrine Testing Market

The Endocrine Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of endocrine disorders globally
    • Increased awareness of the importance of early detection of endocrine disorders
    • Growing adoption of point-of-care testing devices
  • Market Restraints
    • High cost associated with endocrine tests
  • Market Opportunities
    • Expanding technological advancements in assay and testing methods
    • Increasing improvements in healthcare policies and reimbursement systems
  • Market Challenges
    • Reliance on conventional hormone assays

Porter's Five Forces: A Strategic Tool for Navigating the Endocrine Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endocrine Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endocrine Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endocrine Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endocrine Testing Market

A detailed market share analysis in the Endocrine Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endocrine Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endocrine Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endocrine Testing Market

A strategic analysis of the Endocrine Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endocrine Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., BioCheck Inc., Biogenix Inc. Pvt. Ltd, bioMerieux SA, Blueprint Genetics Oy, Creative Diagnostics, Danaher Corporation, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., Eagle Biosciences, EKF Diagnostics Holdings Plc, Eurofins Analytical Laboratories Inc., Getein Biotech, Inc., Laboratory Corporation of America Holdings, MP Biomedicals, LLC, Ortho-Clinical Diagnostics, Inc., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Endocrine Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Insulin Test, Luteinizing Hormone (LH) Test, Progesterone Test, Prolactin Test, Testosterone Test, and Thyroid Stimulating Hormone (TSH) Test.
  • Based on Technology, market is studied across Clinical Chemistry, Immunoassay, and Tandem Mass Spectroscopy.
  • Based on Indication, market is studied across Addison's Disease, Cushing's Disease, Diabetes, Graves' Disease, and Hashimoto Thyroiditis.
  • Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of endocrine disorders globally
      • 5.1.1.2. Increased awareness of the importance of early detection of endocrine disorders
      • 5.1.1.3. Growing adoption of point-of-care testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with endocrine tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding technological advancements in assay and testing methods
      • 5.1.3.2. Increasing improvements in healthcare policies and reimbursement systems
    • 5.1.4. Challenges
      • 5.1.4.1. Reliance on conventional hormone assays
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endocrine Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Cortisol Test
  • 6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
  • 6.4. Estradiol (E2) Test
  • 6.5. Follicle Stimulating Hormone (FSH) Test
  • 6.6. Human Chorionic Gonadotropin (hCG) Hormone Test
  • 6.7. Insulin Test
  • 6.8. Luteinizing Hormone (LH) Test
  • 6.9. Progesterone Test
  • 6.10. Prolactin Test
  • 6.11. Testosterone Test
  • 6.12. Thyroid Stimulating Hormone (TSH) Test

7. Endocrine Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Clinical Chemistry
  • 7.3. Immunoassay
  • 7.4. Tandem Mass Spectroscopy

8. Endocrine Testing Market, by Indication

  • 8.1. Introduction
  • 8.2. Addison's Disease
  • 8.3. Cushing's Disease
  • 8.4. Diabetes
  • 8.5. Graves' Disease
  • 8.6. Hashimoto Thyroiditis

9. Endocrine Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Research Institutes

10. Americas Endocrine Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endocrine Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endocrine Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. Agilent Technologies, Inc.
  • 4. BioCheck Inc.
  • 5. Biogenix Inc. Pvt. Ltd
  • 6. bioMerieux SA
  • 7. Blueprint Genetics Oy
  • 8. Creative Diagnostics
  • 9. Danaher Corporation
  • 10. Diagnostic Automation/Cortez Diagnostics Inc.
  • 11. DiaSorin S.p.A.
  • 12. Eagle Biosciences
  • 13. EKF Diagnostics Holdings Plc
  • 14. Eurofins Analytical Laboratories Inc.
  • 15. Getein Biotech, Inc.
  • 16. Laboratory Corporation of America Holdings
  • 17. MP Biomedicals, LLC
  • 18. Ortho-Clinical Diagnostics, Inc.
  • 19. Quest Diagnostics Incorporated
  • 20. Randox Laboratories Ltd.
  • 21. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • 22. Siemens Healthcare GmbH
  • 23. Thermo Fisher Scientific Inc.
  • 24. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. ENDOCRINE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENDOCRINE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENDOCRINE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENDOCRINE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY FOLLICLE STIMULATING HORMONE (FSH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY LUTEINIZING HORMONE (LH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PROGESTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TESTOSTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 202. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023